| Product Code: ETC9945521 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Graves' Disease Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Graves' Disease Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Graves' Disease Market - Industry Life Cycle |
3.4 United Kingdom (UK) Graves' Disease Market - Porter's Five Forces |
3.5 United Kingdom (UK) Graves' Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United Kingdom (UK) Graves' Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
4 United Kingdom (UK) Graves' Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Graves' disease in the UK |
4.2.2 Advances in medical technology for the treatment of Graves' disease |
4.2.3 Growing prevalence of autoimmune diseases in the UK population |
4.3 Market Restraints |
4.3.1 High costs associated with the treatment of Graves' disease |
4.3.2 Limited access to specialized healthcare services for Graves' disease patients in certain regions of the UK |
4.3.3 Potential side effects and risks of current treatment options for Graves' disease |
5 United Kingdom (UK) Graves' Disease Market Trends |
6 United Kingdom (UK) Graves' Disease Market, By Types |
6.1 United Kingdom (UK) Graves' Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Ultrasound, 2021- 2031F |
6.1.4 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.1.5 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Radioactive Iodine Uptake, 2021- 2031F |
6.1.6 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Blood Sample, 2021- 2031F |
6.2 United Kingdom (UK) Graves' Disease Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Anti-Thyroid Medication, 2021- 2031F |
6.2.3 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Radioactive Iodine Therapy, 2021- 2031F |
6.2.4 United Kingdom (UK) Graves' Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
7 United Kingdom (UK) Graves' Disease Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Graves' Disease Market Export to Major Countries |
7.2 United Kingdom (UK) Graves' Disease Market Imports from Major Countries |
8 United Kingdom (UK) Graves' Disease Market Key Performance Indicators |
8.1 Number of newly diagnosed Graves' disease cases in the UK |
8.2 Percentage of Graves' disease patients receiving timely and appropriate treatment |
8.3 Research and development investments in new therapies for Graves' disease |
8.4 Patient satisfaction and quality of life improvements post-treatment |
9 United Kingdom (UK) Graves' Disease Market - Opportunity Assessment |
9.1 United Kingdom (UK) Graves' Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United Kingdom (UK) Graves' Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10 United Kingdom (UK) Graves' Disease Market - Competitive Landscape |
10.1 United Kingdom (UK) Graves' Disease Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Graves' Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here